09:00 - 10:30
| Nano-manufacturing technologies for life and human health sciences |
SYNOPSIS
|
| HT.III.A.1 |
Gian Gaetano TARTAGLIA CV
Centre for Genomic Regulation & ICREA, Barcelona, Spain
Discovery of Protein-RNA Networks abst
|
| HT.III.A.2 |
Yong CHEN CV
École normale supérieure de Paris, France
Toward large scale application of micro-nano-devices for cancer diagnosis and stem cell studies abst
|
Chair: Luciana DINI
University of Salento, Lecce
|
|
SYNOPSIS
A great challenge is the promotion of the nano-manufacturing technologies to the life and human health science. Unravelling the complexity and functionality of mammalian genomes could open up therapeutic avenues for the treatment of a broad range of neurodegenerative disorders. Functional genomics approaches may elucidate transcriptional cascades at different stages of neurodegenerative disease which may aid in identification of biomarkers. In addition, the same strategy could be used to many other aspect of the degenerative diseases. At the same time, microfluidics, sometimes referred to as lab-on-a-chip, is receiving a lot of attention given its wide array of potential applications Its appeal in life sciences is particularly penetrant. Nevertheless the tremendous progress made during the last decades to promote applications of nano-manufacturing technologies, and especially microfluidic devices, in life sciences it is still challenging to identify large-scale applications. Here we seek to frame some of the emerging themes in this spaces as it evolves, some emerging applications, and an outlook for the evolution of microfluidics/ lab on a chip from end-user markets targeted in the life sciences space.
|
Back to 29 September - Morning
